Literature DB >> 20347553

Folic acid intake among U.S. women aged 15-44 years, National Health and Nutrition Examination Survey, 2003-2006.

Sarah C Tinker1, Mary E Cogswell, Owen Devine, Robert J Berry.   

Abstract

BACKGROUND: In 1998, the IOM recommended all women capable of becoming pregnant consume 400 microg of folic acid daily to prevent neural tube defects (NTDs).
PURPOSE: This paper aims to describe how different sources of folic acid contribute to achieving the recommended usual daily intake.
METHODS: Data on 2617 nonpregnant U.S. women aged 15-44 years from the 2003-2004 and 2005-2006 National Health and Nutrition Examination Surveys were analyzed in 2009. The usual daily folic acid intake from diet and supplements accounting for measurement error; the proportion of women consuming the recommended usual intake; and the adjusted associations of recommended intake with multiple characteristics were estimated.
RESULTS: Overall, 24% of nonpregnant U.S. women of childbearing age consumed the recommended usual intake (95% CI=20%, 27%). Intake was highest among non-Hispanic white women (30%), followed by Mexican-American (17%) and non-Hispanic black women (9%). Among women who used supplements with folic acid, 72% (95% CI=65%, 79%) consumed the recommended usual intake. Use of supplements was the strongest determinant (unadjusted prevalence ratio [PR]: 10.2, 95% CI=7.1, 14.7) of recommended intake, mediating associations of other characteristics. Among the 68% of women who did not use supplements, consumption of cereals with folic acid and having diabetes were the strongest determinants of recommended usual intake (PRs=20.2 and 0.10, respectively).
CONCLUSIONS: Given that consumption of folic acid is an important public health goal to prevent NTDs, an evaluation of strategies, beyond recommendations that women consume supplements, is needed. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347553     DOI: 10.1016/j.amepre.2010.01.025

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  29 in total

1.  Maternal tea consumption during early pregnancy and the risk of spina bifida.

Authors:  Mahsa M Yazdy; Sarah C Tinker; Allen A Mitchell; Laurie A Demmer; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-05-29

2.  Periconceptional intake of vitamins and fetal death: a cohort study on multivitamins and folate.

Authors:  Ellen A Nohr; Jorn Olsen; Bodil H Bech; Lisa M Bodnar; Sjurdur F Olsen; Janet M Catov
Journal:  Int J Epidemiol       Date:  2014-01-21       Impact factor: 7.196

3.  Fortification of corn masa flour with folic acid in the United States.

Authors:  Alan R Fleischman; Motoko Oinuma
Journal:  Am J Public Health       Date:  2011-06-16       Impact factor: 9.308

4.  Periconceptional maternal fever, folic acid intake, and the risk for neural tube defects.

Authors:  Stephen M Kerr; Samantha E Parker; Allen A Mitchell; Sarah C Tinker; Martha M Werler
Journal:  Ann Epidemiol       Date:  2017-11-02       Impact factor: 3.797

5.  What is standing in the way of complete prevention of folate preventable neural tube defects?

Authors:  James L Mills; Aggeliki Dimopoulos; Regan L Bailey
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-07

6.  Strategies for Preventing Folate-Related Neural Tube Defects: Supplements, Fortified Foods, or Both?

Authors:  James L Mills
Journal:  JAMA       Date:  2017-01-10       Impact factor: 56.272

7.  The impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifida.

Authors:  Samantha E Parker; Mahsa M Yazdy; Sarah C Tinker; Allen A Mitchell; Martha M Werler
Journal:  Am J Obstet Gynecol       Date:  2013-05-24       Impact factor: 8.661

8.  Association Between Maternal Multivitamin Use and Preterm Birth in 24 States, Pregnancy Risk Assessment Monitoring System, 2009-2010.

Authors:  Emily O Johnston; Andrea J Sharma; Karon Abe
Journal:  Matern Child Health J       Date:  2016-09

9.  Association of Clomiphene and Assisted Reproductive Technologies With the Risk of Neural Tube Defects.

Authors:  Corey M Benedum; Mahsa M Yazdy; Samantha E Parker; Allen A Mitchell; Martha M Werler
Journal:  Am J Epidemiol       Date:  2016-05-08       Impact factor: 4.897

10.  Preconceptual Folic Acid Use and Recurrence Risk Counseling for Congenital Heart Disease.

Authors:  Shabnam Peyvandi; Jack Rychik; Xuemei Zhang; Judy A Shea; Elizabeth Goldmuntz
Journal:  Congenit Heart Dis       Date:  2014-07-24       Impact factor: 2.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.